By Gina Shaw
Las Vegas—The use of site-of-care (SOC) programs to manage the cost of infused specialty drugs increased significantly again last year, consistent with a multiyear trend toward payor adoption of such programs, according to new data from the 14th edition of EMD Serono Specialty Digest, reported April 30 at Asembia’s 2018 Specialty Pharmacy Summit.
MAY 1, 2018